Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pacritinib vs Best Available Therapy, Including Ruxolitin... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis
0
Authors
John Mascarenhas
18 more
John Mascarenhas
•
Vikas Gupta
16 more
•
Srđan Verstovšek
Published
March 8, 2018
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Oncology
Topics
Medicine
Internal Medicine
Hematology
Surgery
Gastroenterology
Show all topics
DOI
10.1001/jamaoncol.2017.5818
